SELECT TOP (1000) [Source] ,[Taxon] ,[LowValue] ,[HighValue] ,[LowPCile] ,[HighPCile] FROM [DB_A5D9F7_Lassesen].[dbo].[JasonH]

Campylobacterota Details: NCBI 29547, gram-negative or unknown [phylum]

| e-proteobacteria| epsilon proteobacteria| epsilon subdivision| epsilon subgroup| Epsilonproteobacteria| Epsilonproteobacteria Garrity et al. 2006| Proteobacteria epsilon subdivision| Purple bacteria, epsilon subdivision

  1. Gastrointestinal infections: Campylobacter species, particularly Campylobacter jejuni and Campylobacter coli, are major causes of bacterial gastroenteritis in humans. Ingestion of contaminated food, particularly undercooked poultry, unpasteurized milk, and contaminated water, can lead to campylobacteriosis. Symptoms include diarrhea (often bloody), abdominal cramps, fever, nausea, and vomiting. The illness is usually self-limiting, but severe cases may require medical intervention.

  2. Guillain-BarrΓ© syndrome (GBS): Campylobacter infection is a leading trigger for Guillain-BarrΓ© syndrome, a rare but serious autoimmune disorder that affects the peripheral nervous system. It occurs when the body's immune system mistakenly attacks the nerves, leading to muscle weakness, numbness, and, in severe cases, paralysis. The exact mechanism by which Campylobacter infection triggers GBS is not fully understood, but it is believed to involve molecular mimicry, where antibodies generated against Campylobacter cross-react with components of peripheral nerves.

  3. Reactive arthritis: Some individuals infected with Campylobacter may develop reactive arthritis, a form of inflammatory arthritis that occurs in response to certain bacterial infections. Symptoms include joint pain, swelling, stiffness, and inflammation, typically affecting the knees, ankles, and feet. Reactive arthritis usually resolves on its own, but in some cases, symptoms may persist or recur.

  4. Post-infectious irritable bowel syndrome (PI-IBS): Campylobacter infection can lead to post-infectious irritable bowel syndrome (PI-IBS) in some individuals. PI-IBS is a functional gastrointestinal disorder characterized by abdominal pain, bloating, diarrhea, and/or constipation, which persist for weeks to months following an acute gastrointestinal infection. The exact mechanisms underlying the development of PI-IBS after Campylobacter infection are not fully understood but may involve alterations in gut microbiota, immune dysregulation, and mucosal inflammation.

  5. Bacteremia and systemic infections: Although less common than gastrointestinal infections, Campylobacter bacteremia (presence of Campylobacter bacteria in the bloodstream) can occur, particularly in immunocompromised individuals or those with underlying health conditions. Invasive Campylobacter infections can lead to systemic illness, including sepsis, meningitis, and endocarditis, which require prompt medical treatment with antibiotics.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Campylobacterota

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 3.49 0 0 10 53708 0 33790 7372.5 1160 13478.5 0 7580 0 %ile 100 %ile
biomesight 53.52 0 30 10 170 0 6257 464.9 40 2955 0 180 0 %ile 89.6 %ile
thorne 100 172 5163 0 3953 1356.9 741 1324.3 83 3231 0 %ile 100 %ile
thryve 45.49 0 30 1 278 0 10967 796 54 5189.3 0 266 0 %ile 90 %ile
ubiome 33.71 0 48 12 842 0 16970 1994.3 145 7640.5 0 959 0 %ile 92 %ile

External Reference Ranges for Campylobacterota

Campylobacterota (NCBI 29547) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Lab Teletest 0 1000 0 0.1
Statistic by Lab Source for Campylobacterota
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
AmericanGut 40 %   0.724 %  1.541 % 6.0 15
BiomeSight 57.737 %   0.052 %  0.312 % 1653.0 2863
BiomeSightRdp 53.125 %   0.041 %  0.107 % 17.0 32
bugspeak 100 %   0.025 %  % 1.0 1
CerbaLab 66.667 %   0.02 %  0.014 % 2.0 3
CosmosId 9.375 %   0.024 %  0.035 % 3.0 32
custom 47.458 %   1.589 %  1.621 % 28.0 59
es-xenogene 96.552 %   0.216 %  0.139 % 28.0 29
Medivere 100 %   1.658 %  1.391 % 7.0 7
SequentiaBiotech 27.778 %   1.344 %  2.155 % 10.0 36
Thorne 85.227 %   0.081 %  0.104 % 75.0 88
Thryve 45.625 %   0.067 %  0.466 % 631.0 1383
Tiny 100 %   0.002 %  % 1.0 1
uBiome 33.586 %   0.199 %  0.764 % 266.0 792

Symptoms Associated with Campylobacterota From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Amino Acid and similar l-taurine 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style high-fat diets 1 Studies recorded. The consensus is Increases📓, Click for details.
Diet Style ketogenic diet 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style low-fat diets 1 Studies recorded. The consensus is Decreases📓, Click for details.
Drug or "Non-drug" Methylene blue 1 Studies recorded. The consensus is Increases👶, Click for details.
Food (excluding seasonings) navy bean 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) walnuts 1 Studies recorded. The consensus is Decreases📓, Click for details.
Prebiotics and similar carboxymethyl cellulose (prebiotic) 1 Studies recorded. The consensus is Increases📓, Click for details.
Prescription - Other polymannuronic acid 1 Studies recorded. The consensus is Decreases📓, Click for details.
Probiotics bifidobacterium animalis lactis (probiotics) 1 Studies recorded. The consensus is Decreases👶, Click for details.
Probiotics lactobacillus sakei (probiotics) 1 Studies recorded. The consensus is Increases👶, Click for details.
Sugar and similar polysorbate 80 1 Studies recorded. The consensus is Increases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)